PACE Vape Messaging Study

Vaping Clinical Trial

Official title:

Effects of Anti-JUUL-type Messages on Beliefs, Perceived Harms, and Behavioral Intentions Among Young Adults

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04450537
• Other study ID #: 00000693
• Secondary ID: U54DA036114
• Status: Completed
• Phase: N/A
• Start date: June 23, 2020
• Est. completion date: September 30, 2020

Study information

• Verified date: November 2020
• Source: University of Vermont
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to examine the effect of exposure to vape education messages on beliefs, perceptions, norms, and behaviors related to electronic vapor product use.

Description:

Using content developed from the formative research phase, participants in this randomized controlled trial will either be exposed to ten vape education messages or to ten messages on sun safety, with all messages formatted for social media. This study will take place over a 1-month period. Individuals who complete the screening survey and are eligible to participate will be invited to complete a 10-15 minute baseline survey at the start of the study. This survey will ask questions about tobacco and electronic vapor product use, and beliefs about and perceptions of vape products. This survey will also ask about exposure to tobacco and e-cigarette marketing, exposure to prevention messaging on vaping and tobacco use, and peer and family influences on tobacco use. During the survey, participants will be presented with and be asked to provide feedback for short health-related messages. One month after completing this survey, participants will be sent an invitation to the follow-up survey. This survey will again ask about tobacco and electronic vapor product use, and beliefs about and perceptions of vape products. All study procedures will take place remotely, with surveys conducted online. At the end of the first survey, participants will be eligible to receive a $10 online gift card. Upon completion of the follow-up survey, participants will be eligible to receive a $15 online gift card. In total, participants will be eligible to receive up to $25 for completing both surveys. Those who are ineligible will not be asked to complete the baseline survey and will not be compensated.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 569
• Est. completion date: September 30, 2020
• Est. primary completion date: September 30, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 24 Years

Eligibility

Inclusion Criteria:

• Ages 18-24
• Vermont resident
• Access to a smartphone with internet
• Use of one or more social media site(s) at least weekly

Exclusion Criteria:

• Aged 25 years or older
• Not Vermont resident
• No access to a smartphone with internet
• Use of one or more social media site(s) less than weekly

Related Conditions & MeSH terms

• E-cigarette Use
• Electronic Cigarette Use
• Vaping

Intervention

Behavioral:
• Vape Messaging Intervention
Participants will be exposed to 10 vape education messages

Locations

Country	Name	City	State
United States	University of Vermont	Burlington	Vermont

Sponsors (2)

Lead Sponsor	Collaborator
University of Vermont	National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Nicotine/e-cigarette beliefs	True/false/don't know questions about nicotine and electronic vapor/tobacco products	Assessed at 1-month follow-up
Primary	Vape harm perceptions	Harm perception questions about use of electronic vapor/vape products	Assessed at 1-month follow-up
Primary	Vaping-related norms	Questions (5-point Likert scale: 1=Very negative, 5 = Very positive) about others' opinion of using electronic vapor/vape products like JUUL	Assessed at 1-month follow-up
Secondary	Behavioral intentions	Questions about intent to use electronic vapor/vape products in the next 12 months	Assessed at 1-month follow-up

External Links

•   Study website